<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Deng Y</submitter><funding>Non-profit Central Research Institution Fund of Chinese Academy of Medical Sciences</funding><funding>National Natural Science Foundation of China</funding><funding>Sanming Project of Medicine in Shenzhen</funding><funding>CAMS Innovation Fund for Medical Sciences (CIFMS), China</funding><pagination>131</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10190004</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>To explore the clinical prognostic utility of the preoperative cholesterol-to-lymphocyte ratio (CLR) in outcomes for colorectal cancer liver metastasis (CRLM) patients receiving simultaneous resection of the primary lesion and liver metastases.&lt;h4>Methods&lt;/h4>A total of 444 CRLM patients receiving simultaneous resections were enrolled. The optimal cut-off value for CLR was determined using the highest Youden's index. Patients were divided into the CLR &lt; 3.06 group and the CLR≥3.06 group. Propensity score matching analysis (PSM) and the inverse probability of treatment weighting (IPTW) method were conducted to eliminate bias between the two groups. The outcomes included short-term outcomes and long-term outcomes. Kaplan-Meier curves and log-rank tests were used to analyse</pubmed_abstract><journal>BMC surgery</journal><pubmed_title>An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.</pubmed_title><pmcid>PMC10190004</pmcid><funding_grant_id>No. 81972311, 82141127</funding_grant_id><funding_grant_id>No. 2019PT310026</funding_grant_id><funding_grant_id>No. SZSM202011010</funding_grant_id><funding_grant_id>No. 2021-I2M-1-066</funding_grant_id><pubmed_authors>Bi X</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cai J</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Deng Y</pubmed_authors><pubmed_authors>Zhao H</pubmed_authors></additional><is_claimable>false</is_claimable><name>An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.</name><description>&lt;h4>Background&lt;/h4>To explore the clinical prognostic utility of the preoperative cholesterol-to-lymphocyte ratio (CLR) in outcomes for colorectal cancer liver metastasis (CRLM) patients receiving simultaneous resection of the primary lesion and liver metastases.&lt;h4>Methods&lt;/h4>A total of 444 CRLM patients receiving simultaneous resections were enrolled. The optimal cut-off value for CLR was determined using the highest Youden's index. Patients were divided into the CLR &lt; 3.06 group and the CLR≥3.06 group. Propensity score matching analysis (PSM) and the inverse probability of treatment weighting (IPTW) method were conducted to eliminate bias between the two groups. The outcomes included short-term outcomes and long-term outcomes. Kaplan-Meier curves and log-rank tests were used to analyse</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-22T14:50:25.524Z</modification><creation>2025-04-06T01:06:45.544Z</creation></dates><accession>S-EPMC10190004</accession><cross_references><pubmed>37194000</pubmed><doi>10.1186/s12893-023-01988-7</doi></cross_references></HashMap>